Genedrive PLC (LON:GDR) reached a new 52-week low on Wednesday . The stock traded as low as GBX 15 ($0.20) and last traded at GBX 17 ($0.22), with a volume of 128 shares. The stock had previously closed at GBX 17 ($0.22).

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Genedrive in a report on Monday, September 2nd.

The firm has a 50-day moving average of GBX 17.49 and a two-hundred day moving average of GBX 21.02. The firm has a market capitalization of $5.78 million and a P/E ratio of -0.58.

In related news, insider Ian David Gilham purchased 51,250 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were bought at an average cost of GBX 19 ($0.25) per share, with a total value of £9,737.50 ($12,723.77).

Genedrive Company Profile (LON:GDR)

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Featured Story: What is meant by buying and selling pressure?

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.